MAP2K7 and non-small cell lung carcinoma: Finally, we used the NSCLC A549 xenograft tumor model to confirm in vivo that Ech could exert anti-NSCLC effects by inhibiting the activity of the Raf/MEK/ERK signaling pathway to mediate mitochondrial dysfunction and induce pyroptosis.